The U.S. ATP assays market, valued at USD 1.08 billion in 2024, is projected to grow to USD 1.54 billion by 2034, expanding at a CAGR of 3.60% during the forecast period from 2025 to 2034. This steady growth is underpinned by rising demand for rapid microbial detection, increasing investments in life sciences research, and the growing importance...